Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Pathways in cancer | R-HSA-9824443 | map05200 | ursolic acid | 54675769 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | ursolic acid | 54675769 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | ursolic acid | 54675769 | drug-path |
Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | ursolic acid | 54675769 | drug-path |
ErbB signaling pathway | R-HSA-168638 | map04012 | ursolic acid | 54675769 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | ursolic acid | 54675769 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | ursolic acid | 54675769 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | ursolic acid | 54675769 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | ursolic acid | 54675769 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | neomycin | 441 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | neomycin | 441 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | neomycin | 441 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | neomycin | 441 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | isradipine | 3784 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | isradipine | 3784 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | dimenhydrinate | 10660 | drug-path |
Tight junction | R-HSA-2134514 | map04530 | dimenhydrinate | 10660 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | dimenhydrinate | 10660 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | dimenhydrinate | 10660 | drug-path |
TGF-beta signaling pathway | R-HSA-168638 | map04350 | dimenhydrinate | 10660 | drug-path |